Ricordare il futuro - Universita' degli Studi "Magna Graecia"

plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients. GASTROENTEROLOGY,
130 (4): 1098-1106 APR 2006
569. Tamburrini, O; Cova, MA; Console, D; Martingano, P. The evolving role of MRI in
oncohaematological disorders. RADIOLOGIA MEDICA, 112 (5): 703-721 AUG 2007
570. Tassone, P; Tagliaferri, P; Cucinotto, I; Lavecchia, AM; Leone, F; Pietragalla, A; Salvino, A;
Barbieri, V; Venuta, S. Pegylated liposomal doxorubicin is active in Stewart-Treves sindrome. ANNALS
OF ONCOLOGY, 18 (5): 959-960 MAY 2007
571. Tassone, P; Tagliaferri, P; Fulciniti, MT; Di Martino, MT; Venuta, V. Novel therapeutic
approaches based on the targeting of microenvironment-derived survival pathways in human cancer:
Experimental models and translational issues. CURRENT PHARMACEUTICAL DESIGN, 13 (5): 487-
496 2007
572. Tassone, P; Tagliaferri, P; Rossi, M; Gaspari, M; Terracciano, R; Venuta, S. Genetics and
molecular profiling of multiple myeloma: Novel tools for clinical management? EUROPEAN JOURNAL
OF CANCER, 42 (11): 1530-1538 JUL 2006
573. Tassone, P; Neri, P; Kutok, JL; Tournilhac, O; Santos, DD; Hatjiharissi, E; Munshi, V; Venuta, S;
Anderson, KC; Treon, SP; Munshi, NC. A SCID-hu in vivo model of human Waldenstrom
macroglobulinemia. BLOOD, 106 (4): 1341-1345 AUG 15 2005
574. Tassone, P; Neri, P; Carrasco, DR; Burger, R; Goldmacher, VS; Fram, R; Munshi, V; Shammas,
MA; Catley, L; Jacob, GS; Venuta, S; Anderson, KC; Munshi, NC. A clinically relevant SCID-hu in vivo
model of human multiple myeloma. BLOOD, 106 (2): 713-716 JUL 15 2005
575. Tassone, P; Neri, P; Burger, R; Savino, R; Shammas, M; Catley, L; Podar, K; Chauhan, D;
Masciari, S; Gozzini, A; Tagliaferri, P; Venuta, S; Munshi, NC; Anderson, KC. Combination therapy with
interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel
SCID-hu In vivo model of human multiple myeloma. CLINICAL CANCER RESEARCH, 11 (11): 4251-
4258 JUN 1 2005